Protected: FibriCheck’s 2025 wrap-up
This is a password protected post.
This is a password protected post.
FibriCheck entered the U.S. market with FDA-approved heart monitoring technology 2024 was a transformative year for FibriCheck as we achieved FDA clearance (K232804) for our entire ecosystem, including our patient-facing app, AI-powered algorithm, and healthcare provider portal. The FDA-clearance allows…
10 years ago, we set out as pioneers with a bold vision: to empower individuals and healthcare providers with an innovative tool that could detect heart rhythm disorders using nothing more than a smartphone. Today, as we celebrate ten years…
At FibriCheck, we are always innovating and working towards improved efficiency and innovation in heart healthcare. This year, we’ve made important strides towards those goals, as we worked on a variety of interesting projects together with our partners, and made…
After an interesting year filled with milestones like welcoming our millionth user to FibriCheck, achieving reimbursement from healthcare insurers and working on exciting new collaborations, we’re delighted to share our biggest achievements with you.
2019 wrap-up: We started the year with a large screening study conducted with more than 65,000 people. The results from this study were so successful that we got a lot of international attention when we presented them as late breaking…